Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1

Per Løgstrup Poulsen1

  • 1Aarhus Kommunehospital, Aarhus University, Aarhus C, DK-8000, Denmark. perlogstrup@mail.dk

Insights

Diabetic nephropathy affects 25-30% of Type 1 diabetes patients. Early detection via microalbuminuria and managing blood pressure are key to preserving kidney function and reducing mortality.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Diabetic nephropathy impacts 25-30% of Type 1 diabetes mellitus (T1DM) patients.
  • Elevated blood pressure (BP) accelerates progression to end-stage renal failure.
  • Microalbuminuria serves as an early marker for identifying at-risk T1DM patients.

Purpose of the Study:

  • To review early renal changes in T1DM.
  • To explore associations between urinary albumin excretion and various risk factors.
  • To examine differences across normoalbuminuria, progressing, and microalbuminuria groups.

Main Methods:

  • Literature review focusing on early renal involvement in T1DM.
  • Analysis of associations between urinary albumin excretion, glycemic control, smoking, BP, and autonomic function.
  • Comparison of patient groups based on albuminuria levels.

Main Results:

  • Microalbuminuric T1DM patients exhibit characteristic abnormalities including elevated BP, abnormal circadian rhythms, and impaired vagal function.
  • Associated factors include dyslipidemia, endothelial dysfunction, and increased retinopathy prevalence.
  • The review examines links between albuminuria and BP, glycemic control, smoking, and autonomic dysfunction.

Conclusions:

  • Early identification of microalbuminuria is crucial for intervention in T1DM.
  • Multiple factors, including BP and autonomic function, contribute to diabetic nephropathy progression.
  • Understanding these early changes aids in preserving glomerular filtration rate and reducing mortality.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.